Diabetes Cure Blog

According to the scientists of the University of Michigan, they have created a new instrument called as FA device which is capable of detecting the metabolic stress and tissue damage that occurs long before the first symptoms of the diabetes.

A team of researchers at the Jules Stein Eye Institute and other of their counterparts in the USA, have found that the rosiglitazone (Avandia) treated diabetes patients are less likely to develop proliferative diabetic retinopathy. The researchers have tested the records of nearly 124 patients treated with rosiglitazone and compared them with records of 158 [...]

The Pharmaceutical company Pipex Pharmaceutical has announced its plan to acquire worldwide license to the issued and pending patent applications related to additional uses of oral flupirtine for the treatment of a range of ophthalmic, diabetes and diabetes-related therapeutic indications.

Diabetes Prevention Program Research Group has conducted a research on the prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes. Retinopathy is closely related to diabetes. The study has found that problem of retinopathy is present in persons with elevated fasting glucose and impaired glucose tolerance and no known history of diabetes. The prevalence [...]

A report published at the The journal Ophthalmology, shows that Primary open-angle glaucoma, most common form of glaucoma, is more likely to be developed among the diabetic women. The study supports the notion that type 2 diabetes is associated with an increased risk of glaucoma. The study was conducted by researchers at the [...]

Researchers at the Kaiser Permanent, Southern California, found diabetes, if not controlled during pregnancy, can bring problems like still birth, miscarriage and child defects. The study published at the Diabetes Care, shows the number of pregnant women with uncontrolled diabetes are increasing at a large number between year 1999 and 2005. The number is [...]

Australian Researchers at the University of NSW have developed an experimental super drug which could be used to combat a range of illnesses from diabetes to heart disease and cancer.

Research is undergoing to determine whether the experimental drug pirfenidone can slow kidney disease in diabetics. The study is recruiting patients. Pirfenidone has been beneficial in other diseases involving scar formation, such as pulmonary fibrosis and focal segmental glomerulosclerosis. The drug may be able to slow scar formation in diabetic kidney disease as well, possibly [...]

According to the Centers for Disease Control and Prevention, there were 18.2 million people with diabetes in 2002, and 5.2 million, it was estimated, didn’t know they had the disease.

The FDA alerted Medwatch about numerous reports that Avandia, a diabetes drug manufactured by GlaxoSmithKline, has been causing a swelling at the back of the eye known as macular edema.